Table 3.

IC₅₀ of WJMSCs-norCM and WJMSCs-hypoCM in BC cell lines for 72 h incubation

Cell lines	IC 50 (%)
	WJMSCs-norCM		WJMSCs-hypo5%CM		WJMSCs-hypo2.5%CM
	Passage 4	Passage 8	Passage 4	Passage 8	Passage 4	Passage 8
MCF7	42.34 ± 4.94	49.51 ± 2.13	52.10 ± 10.16	54.1 ± 3.32	57.93 ± 15.49	62.84 ± 7.95
T47D	44.87 ± 3.50	42.36 ± 2.49	51.98 ± 2.16	48.06 ± 4.08	56.27 ± 5.42	58.96 ± 7.22

Data are expressed as IC₅₀ values (%); the anticancer activity of the WJMSCs-CM effect toward BC cell lines (MCF7 and T47D). The experiment was conducted in triplicate for each treatment.